{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:40:22Z","timestamp":1649112022735},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00347-013-2976-x","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T08:44:32Z","timestamp":1384418672000},"page":"1079-1096","source":"Crossref","is-referenced-by-count":3,"title":["Update endokrine Orbitopathie"],"prefix":"10.1007","volume":"110","author":[{"given":"A.","family":"Eckstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Berchner-Pfannschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"key":"2976_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","volume":"26","author":"Iyer","year":"2012","unstructured":"Iyer S, Bahn R (2012) Immunopathogenesis of Graves\u2018 ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab 26(3):281\u2013289","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2976_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.beem.2011.10.002","volume":"26","author":"Smith","year":"2012","unstructured":"Smith TJ, Hegedus L, Douglas RS (2012) Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves\u2018 orbitopathy. Best Pract Res Clin Endocrinol Metab 26(3):291\u2013302","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2976_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","volume":"41","author":"Eckstein","year":"2009","unstructured":"Eckstein AK et al (2009) Current insights into the pathogenesis of Graves\u2018 orbitopathy. Horm Metab Res 41(6):456\u2013464","journal-title":"Horm Metab Res"},{"key":"2976_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.2010.04219.x","volume":"162","author":"Smith","year":"2010","unstructured":"Smith TJ (2010) Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy. Clin Exp Immunol 162(1):24\u201331","journal-title":"Clin Exp Immunol"},{"key":"2976_CR5","first-page":"9","volume":"Endocrinol","author":"Mourits","year":"1997","unstructured":"Mourits MP et al (1997) Clinical activity score as a guide in the management of patients with Graves\u2018 ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9\u201314","journal-title":"Clin"},{"key":"2976_CR6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","volume":"93","author":"Eckstein","year":"2009","unstructured":"Eckstein A et al (2009) Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetric Graves ophthalmopathy. Br J Ophthalmol 93:1052\u20131056","journal-title":"Br J Ophthalmol"},{"key":"2976_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/thy.1998.8.423","volume":"8","author":"Perros","year":"1998","unstructured":"Perros P, Kendall-Taylor P (1998) Natural history of thyroid eye disease. Thyroid 8(5):423\u2013425","journal-title":"Thyroid"},{"key":"2976_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"Bartalena","year":"2008","unstructured":"Bartalena L et al (2008) Consensus statement of the European Group on Graves\u2018 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"2976_CR9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"Marcocci","year":"2011","unstructured":"Marcocci C et al (2011) Selenium and the course of mild Graves\u2018 orbitopathy. N Engl J Med 364(20):1920\u20131931","journal-title":"N Engl J Med"},{"key":"2976_CR10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"Zang","year":"2011","unstructured":"Zang S, Ponto KA, Kahaly GJ (2011) Clinical review: Intravenous glucocorticoids for Graves\u2018 orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab 96(2):320\u2013332","journal-title":"J Clin Endocrinol Metab"},{"key":"2976_CR11","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"Bartalena","year":"2012","unstructured":"Bartalena L et al (2012) Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2018 orbitopathy. J Clin Endocrinol Metab 97(12):4454\u20134463","journal-title":"J Clin Endocrinol Metab"},{"key":"2976_CR12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","volume":"355","author":"Mourits","year":"2000","unstructured":"Mourits MP et al (2000) Radiotherapy for Graves\u2018 orbitopathy: randomised placebo-controlled study. Lancet 355(9214):1505\u20131509","journal-title":"Lancet"},{"key":"2976_CR13","first-page":"145","volume":"Endocrinol","author":"Terwee","year":"2005","unstructured":"Terwee CB et al (2005) Measuring disease activity to predict therapeutic outcome in Graves\u2018 ophthalmopathy. Clin Endocrinol (Oxf) 62(2):145\u2013155","journal-title":"Clin"},{"key":"2976_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9394(14)73194-0","volume":"116","author":"Garrity","year":"1993","unstructured":"Garrity JA et al (1993) Results of transantral orbital decompression in 428 patients with severe Graves\u2018 ophthalmopathy. Am J Ophthalmol 116(5):533\u2013547","journal-title":"Am J Ophthalmol"},{"key":"2976_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","volume":"156","author":"Salvi","year":"2007","unstructured":"Salvi M et al (2007) Treatment of Graves\u2018 disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol 156(1):33\u201340","journal-title":"Eur J Endocrinol"},{"key":"2976_CR16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00347-007-1592-z","volume":"104","author":"Wabbels","year":"2007","unstructured":"Wabbels B, Forl M (2007) Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction. Ophthalmologe 104(9):771\u2013776","journal-title":"Ophthalmologe"},{"key":"2976_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2011.10.005","volume":"26","author":"Lazarus","year":"2012","unstructured":"Lazarus JH (2012) Epidemiology of Graves\u2018 orbitopathy (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26(3):273\u2013279","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2976_CR18","first-page":"343","volume":"Klin","author":"Eckstein","year":"2009","unstructured":"Eckstein A et al (2009) Role of TSH receptor autoantibodies for the diagnosis of Graves\u2018 disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the thyroid section of the German Society of Endocrinology. Med Klin (Munich) 104(5):343\u2013348","journal-title":"Med"},{"key":"2976_CR19","first-page":"607","volume":"Endocrinol","author":"Eckstein","year":"2007","unstructured":"Eckstein AK et al (2007) Patients with severe Graves\u2018 ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clin Endocrinol (Oxf) 67(4):607\u2013612","journal-title":"Clin"},{"key":"2976_CR20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2010-2329","volume":"96","author":"Bartalena","year":"2011","unstructured":"Bartalena L (2011) The dilemma of how to manage Graves\u2018 hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab 96(3):592\u2013599","journal-title":"J Clin Endocrinol Metab"},{"key":"2976_CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.beem.2011.11.002","volume":"26","author":"Eckstein","year":"2012","unstructured":"Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves\u2018 ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26(3):339\u2013358","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2976_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/eye.2012.284","volume":"27","author":"Verity","year":"2013","unstructured":"Verity DH, Rose GE (2013) Acute thyroid eye disease (TED): principles of medical and surgical management. Eye 27(3):308\u2013319","journal-title":"Eye"},{"key":"2976_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/01676830.2010.508000","volume":"29","author":"Baldeschi","year":"2010","unstructured":"Baldeschi L (2010) Small versus coronal incision orbital decompression in Graves\u2018 orbitopathy. Orbit 29(4):177\u2013182","journal-title":"Orbit"},{"key":"2976_CR24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajo.2005.04.023","volume":"140","author":"Baldeschi","year":"2005","unstructured":"Baldeschi L et al (2005) The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. Am J Ophthalmol 140(4):642\u2013647","journal-title":"Am J Ophthalmol"},{"key":"2976_CR25","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ophtha.2004.01.026","volume":"111","author":"Kalpadakis","year":"2004","unstructured":"Kalpadakis P et al (2004) Muscle surgery in patients with Graves\u2018 disease using topical anesthesia. Ophthalmology 111(8):1563\u20131568","journal-title":"Ophthalmology"},{"key":"2976_CR26","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1055\/s-0029-1212189","volume":"107","author":"Esser","year":"1999","unstructured":"Esser J, Eckstein A (1999) Ocular muscle and eyelid surgery in thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 107(Suppl 5):S214\u2013S221","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2976_CR27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0031-1281776","volume":"228","author":"Esser","year":"2011","unstructured":"Esser J, Schittkowski M, Eckstein A (2011) Graves\u2018 orbitopaty: inferior rectus tendon elongation for large vertical squint angles that cannot be corrected by simple muscle recession. Klin Monatsbl Augenheilkd 228(10):880\u2013886","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2976_CR28","doi-asserted-by":"crossref","unstructured":"Neoh C, Eckstein A (2010) Eyelid surgery. In: Wiersinga WM, Kahaly GJ (Hrsg) Graves\u2018 orbitopathy: a multidisciplinary approach \u2013 questions and answers. Karger, Basel, S\u00a0200\u2013210","DOI":"10.1159\/000320440"},{"key":"2976_CR29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.75.6.344","volume":"75","author":"Mourits","year":"1991","unstructured":"Mourits MP, Koornneef L (1991) Lid lengthening by sclera interposition for eyelid retraction in Graves\u2018 ophthalmopathy. Br J Ophthalmol 75(6):344\u2013347","journal-title":"Br J Ophthalmol"},{"key":"2976_CR30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1055\/s-0031-1281775","volume":"228","author":"Eckstein","year":"2011","unstructured":"Eckstein A, Esser J (2011) A temporal tarsorrhaphy increases the effect of lower lid lengthening in patients with Graves\u2018 orbitopathy. Klin Monatsbl Augenheilkd 228(10):887\u2013891","journal-title":"Klin Monatsbl Augenheilkd"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-013-2976-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2976-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T20:26:09Z","timestamp":1564691169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-013-2976-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1007\/s00347-013-2976-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}